Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial
纳武利尤单抗联合伊匹木单抗与纳武利尤单抗单药治疗复发或转移性头颈部鳞状细胞癌的疗效和安全性:CheckMate 714 II期随机临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2023.0147
Harrington, Kevin J; Ferris, Robert L; Gillison, Maura; Tahara, Makoto; Argiris, Athanasios; Fayette, Jérôme; Schenker, Michael; Bratland, Åse; Walker, John W T; Grell, Peter; Even, Caroline; Chung, Christine H; Redman, Rebecca; Coutte, Alexandre; Salas, Sébastien; Grant, Cliona; de Azevedo, Sergio; Soulières, Denis; Hansen, Aaron R; Wei, Li; Khan, Tariq Aziz; Miller-Moslin, Karen; Roberts, Mustimbo; Haddad, Robert